HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma

BACKGROUND: Immunotherapy for human hepatocellular cancer (HCC) is slowly making progress towards treating these fatal cancers. The identification of new antigens can improve this approach. We describe a possible new antigen, hepatocellular carcinoma‐associated antigen‐519/targeting protein for Xklp...

Descripción completa

Detalles Bibliográficos
Autores principales: Aref, Ahmed M, Hoa, Neil T, Ge, Lisheng, Agrawal, Anshu, Dacosta-Iyer, Maria, Lambrecht, Nils, Ouyang, Yi, Cornforth, Andrew N, Jadus, Martin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063820/
https://www.ncbi.nlm.nih.gov/pubmed/24966688
http://dx.doi.org/10.2147/OTT.S61442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063820/
https://www.ncbi.nlm.nih.gov/pubmed/24966688
http://dx.doi.org/10.2147/OTT.S61442

Ejemplares similares